Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe(2)
添加时间:2010-08-02 原文发表:2010-08-02 人气:79
本文章共2117字，分2页，当前第2页，快速翻页：
http://www.sec.gov/. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
Source: Bionovo, Inc.
CONTACT: Tom Chesterman, +1-510-601-2000, investor@bionovo.com; or
Investors, Joe Diaz, Robert Blum or Joe Dorame, all of Lytham Partners, LLC,
+1-602-889-9700, bnvi@lythampartners.com, for Bionovo, Inc.